Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 11, 2023

SELL
$135.66 - $197.02 $12,209 - $17,731
-90 Reduced 4.92%
1,739 $267,000
Q4 2022

Jan 19, 2023

BUY
$118.38 - $210.04 $216,517 - $384,163
1,829 New
1,829 $0
Q1 2022

Apr 27, 2022

SELL
$126.46 - $235.05 $98,006 - $182,163
-775 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $175,010 - $285,595
775 New
775 $196,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.